Ctc Capital Management, LLC Cyma Bay Therapeutics, Inc. Transaction History
Ctc Capital Management, LLC
- $47.2 Million
- Q1 2023
A detailed history of Ctc Capital Management, LLC transactions in Cyma Bay Therapeutics, Inc. stock. As of the latest transaction made, Ctc Capital Management, LLC holds 10,700 shares of CBAY stock, worth $0. This represents 0.2% of its overall portfolio holdings.
Number of Shares
10,700Holding current value
$0% of portfolio
0.2%Shares
1 transactions
Others Institutions Holding CBAY
# of Institutions
11Shares Held
1.88MCall Options Held
0Put Options Held
0-
Foresite Capital Management Iii, LLC Larkspur, CA1.64MShares$015.17% of portfolio
-
Abingworth LLP London, X0131KShares$00.27% of portfolio
-
Golden State Equity Partners South Coast Metro, CA54.3KShares$00.32% of portfolio
-
Connacht Asset Management LP New York, NY12KShares$01.09% of portfolio
-
Pictet Asset Management Sa Geneva 73, V810.6KShares$00.0% of portfolio
About CymaBay Therapeutics, Inc.
- Ticker CBAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,677,904
- Description
- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...